FICAM (Finnish Centre for Alternative Methods)

FICAM (Finnish Centre for Alternative Methods)

FICAM (Finnish Centre for Alternative Methods) was established in December 2008. FICAM is located in the Faculty of Medicine and Life Sciences at the University of Tampere. The Faculty has long experience in human cell and tissue research and development on related technology.

FICAM is the centre of expertise for alternative methods to animal experimentation in Finland. FICAM develops and validates human-cell-based tissue/organ models, shares information on alternative methods, educates experts, and acts as the Finnish reference laboratory for EURL-ECVAM (European Union Reference Laboratory for Alternatives to Animal Testing). The basis of FICAM’s activity lays on EU directive 2010/63, according to which the use of experimental animals should be reduced and animal tests to be replaced with non-animal approaches in research and education as soon as it is scientifically possible.

FICAM actively promotes alternative approaches at national and EU levels in many ways, e.g. by participating in expert groups and administrative appointments concerning the promotion of alternative methods. Tuula Heinonen, the director of FICAM, is the Finnish representative (contact point) in the PARERE (Preliminary Assessment of Regulatory Relevance) Network under Article 47(5) of Directive 2010/63/EU. Further FICAM is coordinating the Finland´s 3R Consortium.

Here is an overview of European 3R Centres.

This page was updated on 31 May 2019

Did you find what you were looking for?

Yes, I found it! No, I did not!

Thanks for your feedback! Please note that we cannot respond unless you supply your email address.

What are you looking for?

Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.

Please contact us by email if you have any questions.

Thanks for your feedback! Please note that we cannot respond unless you supply your email address.



 

Abonnér på nyhetsbrevene fra Norecopa